Previous 10 | Next 10 |
BIO-TECHNE ISSUES 2023 CORPORATE SUSTAINABILITY REPORT PR Newswire MINNEAPOLIS , Sept. 25, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today issued its 2023 Corporate Sustainability Report (CSR), detailing the continued progress advancing its Envir...
2023-09-23 09:00:07 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips As of September 19, S&P 500 healthcare stocks were down 3.2% for the year. Of the 11 sectors, its year to date ( YTD ) performance is the second worst only beh...
Cizzle and Bio-Techne Announce Completion of Evaluation Programme for Detection of CIZ1B Using ProteinSimple Branded Simple Western™ Platform PR Newswire LONDON and MINNEAPOLIS , Sept. 19, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) and ...
BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES PR Newswire MINNEAPOLIS , Aug. 28, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it will present at the following investor healthcare conferences: 2023 Wells Fargo Healthcare C...
BIO-TECHNE ANNOUNCES 2023 INVESTOR DAY AND WEBCAST PR Newswire MINNEAPOLIS , Aug. 24, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host its 2023 Investor Day on Friday, September 8, 2023 , starting at ...
2023-08-22 04:17:02 ET Summary Bio-Techne Corporation's share price has declined by over 10% in the past year, and its valuation is high at over 40x earnings. The company has acquired Lunaphore to drive growth in spatial biology solutions and maintain a leading market position. ...
BIO-TECHNE TO PRESENT AT THE UBS MEDTECH, TOOLS AND GENOMICS SUMMIT 2023 PR Newswire MINNEAPOLIS , Aug. 15, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Jim Hippel , Executive Vice President and Chief Financial Officer, will...
2023-08-14 08:15:00 ET Summary This article provides a dashboard with industry metrics in healthcare, then focus on the Global X Genomics & Biotechnology ETF. Pharmaceuticals/biotechnology and healthcare providers have fair value and quality scores. Healthcare equipment is...
BIO-TECHNE ENDS COLLABORATION PROGRAM WITH AKOYA TO AUTOMATE RNASCOPE ON THE PHENOCYCLER FUSION PR Newswire MINNEAPOLIS , Aug. 14, 2023 /PRNewswire/ -- Bio-Techne (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for...
2023-08-08 15:49:10 ET Bio-Techne Corporation (TECH) Q4 2023 Earnings Conference Call August 08, 2023 9:00 AM ET Company Participants David Clair – Vice President-Investor Relations Chuck Kummeth – Chief Executive Officer Jim Hippel – Chief F...
News, Short Squeeze, Breakout and More Instantly...
BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 7, 2024, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2024 FINANCIAL RESULTS PR Newswire MINNEAPOLIS , July 15, 2024 /PRNewswire/ -- Bio-Techne Corporation ( NASDAQ : TECH) today announced that management will host a co...
BIO-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES PR Newswire MINNEAPOLIS , May 31, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman , President and Chief Executive Officer will present at the following invest...